Safe Use of Phenergan in Elderly Patients

Primary Safety Concerns

The American Geriatrics Society recommends avoiding first-generation antihistamines like promethazine in older adults due to significant risks of CNS impairment, falls, anticholinergic toxicity, and respiratory depression, with safer alternatives available for most indications 1, 2
First-generation antihistamines are associated with CNS impairment, including delirium, slowed comprehension, and over-sedation, in elderly patients 1
Anticholinergic effects of first-generation antihistamines, such as impaired vision, urinary retention, constipation, and confusion, are a concern in elderly patients 1

The American Geriatrics Society explicitly identifies first-generation antihistamines, including promethazine, as potentially inappropriate medications for older adults due to strong anticholinergic properties and sedating effects 1, 2, 3
The American Geriatrics Society recommends prioritizing non-pharmacological interventions over promethazine for behavioral symptoms in elderly patients 6

Reduced renal clearance in elderly patients delays the elimination of promethazine, increasing the risk of adverse effects 5
Increased CNS sensitivity to sedating and anticholinergic effects of promethazine is a concern in elderly patients 4

Failing to recognize significant renal impairment in elderly patients with normal serum creatinine due to reduced muscle mass can lead to adverse effects from promethazine 5
Underestimating anticholinergic burden in patients with pre-existing cognitive impairment, benign prostatic hypertrophy, or glaucoma can increase the risk of adverse effects from promethazine 4

Second-generation antihistamines, such as fexofenadine, loratadine, or desloratadine, are preferred over promethazine due to their lack of sedation and anticholinergic effects at recommended doses 4
Second-generation antihistamines have not been associated with performance impairment or increased fall risk in elderly patients 4